Healthcare Staffing Market is Led by Hospital Category

The healthcare staffing market is estimated to generate USD 40.1 billion in 2023, which will touch USD 64.2 billion, advancing at a 7.0% compound annual growth rate, by 2030.

The progression of this industry is mainly because of the high working flexibility as well as the surging occurrence of chronic ailments. Furthermore, the consciousness about the advantages of temporary employment, availability of opportunities, and incentives associated with the job has surged.

The travel nurse staffing category, based on service type, is leading the industry, with a 40% share. This can be because of the lack of skilled nurses as well as the necessity for their constant accessibility and cost-efficiency. Because of the rising healthcare expenditures during the pandemic of COVID-19, health centers were forced to reduce their employees.

The hospitals category, based on end user, is the largest contributor to the healthcare staffing market. This is because numerous hospitals are hiring skilled specialists in accordance with the rules implemented by governments to maintain an ideal nurse-to-patient ratio. Therefore, the employment of patient-centric rules is boosting the count of staff members in health centers.

APAC is likely to advance at the fastest rate, of 7.5%, during this decade. This is ascribed to the increasing need for workers to work for a specific period in this region.

Europe will also propel at a significant rate, because of the enormous lack of healthcare workers it has been facing for several years now.

With the surging incidence of chronic ailments and the high working flexibility, the healthcare staffing industry will continue to progress in the coming years.

Read More

North America Is Dominating Ultrasound Probe Covers Industry

The total value of the global ultrasound probe covers market was USD 203.1 million in 2022, and it will rise at a growth rate of above 7.4%, reaching USD 358.9 million by 2030.

To learn more about this report: https://bit.ly/3srNLTU

The growth in everyday cases associated with urological and gynecological syndromes and infectious illnesses has augmented the utilization of ultrasound and the growth of progressive technology in ultrasonic imaging. However, there is a high possibility of contagion from transducers during ultrasonic imaging. After the COVID-19 epidemic, there is a high emphasis on the well-being of patients from infectious illnesses via ultrasound probes, which leads to the augmented use of protective covers.

In 2022, the disposable type category contributed the larger revenue share, of above USD 190 million. This can be credited to its cost-efficiency and the capability to lessen the danger of illness or infection spread among patients.

Throwaway or single-use medicinal equipment covers are usually suitable and simple to use, as they can be swiftly disposed of after every use. This fortifies them to be extremely chosen by healthcare workers who prioritize infection control and operational effectiveness. 

Moreover, their throwaway nature guarantees a progressive level of hygiene and safety from infection and decreases the load of cleaning and sterilization procedures.

On the basis of product type, the market is bifurcated into latex-free and latex probe covers. Between these two, the latex category holds a larger industry share and the category is also projected to advance at a significant pace in the future. This is mainly because latex protective covers are usually more inexpensive than other kinds and are effortlessly accessible primarily in emerging nations with imperfect healthcare amenities. In such countries, healthcare specialists are seeking a balance between price and patient well-being, and latex kind is a better choice for infection control.

The endocavity category is generating a larger revenue share. This is because of the growing demand for endo-cavity ultrasound procedures, mainly in the fields of gynecology, obstetrics, and age-related chronic illnesses. Furthermore, a medicinal probe cover is precisely made for utilization in endocavity procedures that include inserting the ultrasound probe into body cavities like the rectum and vagina. These covers are used to avoid contamination of the examination site from liquids or other materials that can possibly reason infections if they enter via open injuries during ultrasonic imaging.

North America is dominating the industry. This can be ascribed to the growing obtainability of medicinal repayments for ultrasound procedures, the increasing count of diagnostic centers and infirmaries, the non-invasive nature of ultrasound technology and its capability to make real-time photos, and the existence of key market players in the continent.

Read More

How is Expanding Patient Pool Fueling Embolotherapy Industry Growth?

The global embolotherapy industry is experiencing growth and is projected to reach 6,447.1 million by 2030, according to P&S Intelligence. This growth can be ascribed to the rising patient pool, mounting occurrence of chronic and lifestyle-related illnesses, growing healthcare investments, and advancing healthcare infrastructure.

To learn more about this report: https://bit.ly/43NzT3S

In recent years, embolic agents led the industry, on the basis of product. The growing utilization of embolic agents in numerous interventional radiology procedures is the major factor for this product category's supremacy in the industry.

Moreover, because of the improvements in such agents, including drug-eluting microspheres, standardized microspheres for bland embolization, and radioactive yttrium-90 (Y-90) microspheres, for curing primary or secondary liver illness, the category is projected to advance at a higher rate in the coming few years.

In recent years, North America led the embolotherapy market, and it is projected to grip the largest industry share in the future as well. The growing occurrence of signs that need embolization procedures, well-known healthcare infrastructure, and the growth of progressive embolic agents by the players functioning in the continent are some of the key factors for the development of the North American industry.

The extended exposure to four modifiable lifestyle behaviors, mainly physical inactivity, smoking, alcohol consumption, and unhealthy diet, commonly results in chronic illnesses, such as diabetes, stroke, metabolic syndrome, obesity, chronic obstructive pulmonary illness, and numerous kinds of cancer.

Chronic illnesses are a key healthcare load impacting high-income as well as low- and middle-income nations (LMICs). Hepatitis, cancer, and central nervous system syndromes are some of the chronic illnesses that need progressive treatment. Therefore, the surge in the occurrence of chronic and lifestyle-related illnesses is boosting the embolotherapy industry worldwide.

Hence, the growing patient pool, mounting occurrence of chronic and lifestyle-related illnesses, growing healthcare investments, and advancing healthcare infrastructure, such factors are propelling embolotherapy market.

Read More